Our Mission
MeiRui's mission is to provide people suffering from diseases with the best products and services available. The Company constantly strives to improve its ability to offer innovative products and to make sure they are delivered to those in need.

Our Goal
MeiRui's goal is to be a leading Chinese pharmaceutical and diagnostic company in the field of urology, and to constantly add new products that treat conditions affecting the elderly. Meirui's Goal is also to always act with compassion, caring and understanding in improving the health and well being of the Chinese people.

MeiRui's Major Products

The following are the general description of the major MeiRui products. Also shown is the Clinical Handbook. At the end of each product description is a link to additional information for patients and doctors. On those pages are product inserts, product brochures and other documents for both doctors or patients. Those documents are written in Chinese, as you would expect.

General Information: MeiRui Pharma Clinical Handbook

Prostat is a treatment for Benign prostatic hyperplasia (BPH) and chronic non-bacteria prostatitis, the most common urinary diseases among mature men. Prostat is an effective BPH therapy with low adverse effects. Prostat is also the only approved therapy for prostatitis, a difficult to treat condition, almost as common as BPH. Recent scientific finding indicate that Prostat's anti-inflammatory action may actually slow the onset of BPH and therefore be an effective prophylactic for the onset for that condition. Click here for more information about Prostat.

SheNiTing (Tolterodine) is indicated for the treatment of patients with overactive bladder (OAB). OAB is a condition where you have frequent and strong urges to go to the bathroom (urinate). This condition affects a large percentage of mature women and some men. In men, OAB can be associated with BPH. OAB can be an embarrassing condition that can have dramatic affects on the quality of day to day life. SheNiTing acts by calming and controlling frequent contractions of the bladder muscle, the cause of the urge to urinate.
Setrole is MeiRui's once a day version of its OAB therapeutic. Click here for more information about SheNiTing and Setrole.

Urexact is digital urine monitoring system used for to measure the urine output of intensive care patients. Urexact is a next generation system that is much more precise then existing urine collection bags. In addition, Urexact gives advance information on kidney function and may allow for the early detection of kidney distress or kidney failure, a very common occurrence in critically ill patients. Click here for more information about Urexact.

ImmunoCAP is a complete automated system of instrumentation, software and reagents to determine the type and quantity of hundreds of allergen producing antibodies. The ImmunoCAP system is manufactured by Phadia, the world's leader in immuno-diagnostic automated systems. The ImmunoCAP system allows physicians to determine the exact cause or causes of the allergies and asthma that affect a high percentage of the population. ImmunoCAP uses a small blood sample to determine which allergen antibodies (IgE, IgG and IgA) are present, and to determine the quantity of each of these antibodies. Click here for more information about ImmunoCAP.